BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/26/2014 11:43:00 AM | Browse: 1061 | Download: 752
Publication Name World Journal of Gastroenterology
Manuscript ID 7745
Country Switzerland
Received
2013-11-30 12:32
Peer-Review Started
2013-11-30 13:42
To Make the First Decision
2014-01-15 19:13
Return for Revision
2014-01-20 22:26
Revised
Second Decision
2014-04-09 09:16
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2014-04-09 09:39
Articles in Press
2014-05-23 09:49
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2014-06-12 18:54
Publish the Manuscript Online
2014-07-03 15:30
ISSN 1007-9327 (print) and 2219-2840 (online)
Open Access
Copyright
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Gastroenterology & Hepatology
Manuscript Type Review
Article Title Portopulmonary hypertension and hepatopulmonary syndrome
Manuscript Source Invited Manuscript
All Author List Florence Aldenkortt, Marc Aldenkortt, Laurence Caviezel, Jean Luc Waeber, Anne Weber and Eduardo Schiffer
Funding Agency and Grant Number
Corresponding Author Florence Aldenkortt, MD, Staff Anesthesiologist, Division of Anesthesiology, Department of Anesthesiology, Clinical Pharmacology and Intensive Care, Geneva University Hospitals, Rue Gabrielle-Perret-Gentil 4, 1211 Geneva, Switzerland. florence.aldenkortt@hcuge.ch
Key Words End stage liver disease; Hepatopulmonary syndrome; Portopulmonary Hypertension; Anesthesia
Core Tip Portopulmonary hypertension (POPH) and hepatopulmonary syndrome (HPS) are frequent complications of liver disease. Both conditions result from diminished hepatic clearance of splanchnic vasoactive substances. They cause pulmonary vasoconstriction in POPH resulting in elevated pulmonary pressure, right ventricular dysfunction and intrapulmonary shunts with hypoxemia in HPS. The only lasting treatment is liver transplantation (LT). Whereas LT results in the disappearance of HPS, its effect on POPH is unpredictable. The anesthesiologist plays a central role in managing HPS and POPH during LT as preoperative screening and grading of the disease allows the selection of appropriate therapies.
Publish Date 2014-07-03 15:30
Citation Aldenkortt F, Aldenkortt M, Caviezel L, Waeber JL, Weber A, Schiffer E. Portopulmonary hypertension and hepatopulmonary syndrome. World J Gastroenterol 2014; 20(25): 8072-8081
URL http://www.wjgnet.com/1007-9327/full/v20/i25/8072.htm
DOI http://dx.doi.org/10.3748/wjg.v20.i25.8072
Full Article (PDF) WJG-20-8072.pdf
Full Article (Word) WJG-20-8072.doc
Manuscript File 7745-Review.docx
Answering Reviewers 7745-Answering reviewers.pdf
Copyright License Agreement 7745-Copyright assignment.pdf
Peer-review Report 7745-Peer review(s).pdf
Scientific Editor Work List 7745-Scientific editor work list.doc